Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.47
-0.0600-3.92%
Post-market: 1.44-0.0300-2.04%18:54 EDT
Volume:470.98K
Turnover:709.03K
Market Cap:159.17M
PE:-1.02
High:1.55
Open:1.50
Low:1.47
Close:1.53
Loading ...
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 26, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Major Issues Report

8-K - Current report
Jun 03, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 22, 2021

Major Issues Report

8-K - Current report